CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Propharex is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Propharex
Rue du Luxemburg, 13
Phone: 32 71469632p:32 71469632 Courcelles, 6180  Belgium Ticker: PROPPROP
Propharex declared bankruptcy on June 28, 2011. The company's shares will be delisted.
This company is no longer actively traded on any major stock exchange.
Business Summary
Propharex SA is a Belgium-based company engaged in the design, construction and sale of modular pharmaceutical laboratories as well as the production of pharmaceuticals and cosmetic products. The Company's activities are divided into four divisions: the construction and sale of production units for generic pharmaceuticals, aimed at third world countries; the production of generic pharmaceuticals; the production of over-the-counter (OTC) drugs, such as aroma therapies and insect repellents; the production of cosmetics through its Propharex Cosmetique subsidiary. Propharex SA announced that it has been declared bankrupt effective June 28, 2011. The Company filed for bankruptcy on June 22, 2011. The Company's shares will be delisted.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/200912/31/2009Yes----

Industries
SIC Code Description
1541 General contractors-industrial buildings and warehouses
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Appointed Managing Director, Member of the Board of Directors Jean-FrancoisCapart
Appointed Managing Director, Member of the Board of Directors Jean-PierreRaemdonck
Member of the Board of Directors Jean-MarieDevos
Member of the Board of Directors representing Biotec SA PierrickHalflants

Business Names
Business Name
PROP
Propharex

General Information
Number of Employees: 23 (As of 12/31/2009)
Outstanding Shares: 2,388,998 (As of 12/31/2009)
Stock Exchange: EBR
Fax Number: 32 71469639
Email Address: info@propharex.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023